Ekaterina Maslova
Overview
Explore the profile of Ekaterina Maslova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tran T, Heatley H, Bourdin A, Menzies-Gow A, Jackson D, Maslova E, et al.
J Asthma Allergy
. 2024 Jun;
17:573-587.
PMID: 38919734
Purpose: Oral corticosteroid (OCS) use for asthma is associated with considerable healthcare resource utilization (HCRU) and costs. However, no study has investigated this in relation to patterns of intermittent OCS...
2.
Wilkinson A, Maslova E, Janson C, Radhakrishnan V, Quint J, Budgen N, et al.
Thorax
. 2024 Feb;
PMID: 38413192
Background: Poorly controlled asthma is associated with increased morbidity and healthcare resource utilisation (HCRU). Therefore, to quantify the environmental impact of asthma care, this retrospective, cohort, healthCARe-Based envirONmental cost of...
3.
Alzaabi A, Bell J, Montero-Arias F, Price D, Jackson D, Wang H, et al.
Adv Ther
. 2023 Sep;
40(11):4836-4856.
PMID: 37684493
Introduction: Healthcare systems are looking to reduce their carbon impact. Short-acting β-agonist (SABA) overuse (≥ 3 canisters/year) is common in asthma and linked to poor outcomes; however, its environmental impact...
4.
Kallis C, Maslova E, Morgan A, Sinha I, Roberts G, van der Valk R, et al.
Thorax
. 2023 Jul;
78(12):1175-1180.
PMID: 37524391
Background: Asthma-related burden remains poorly characterised in children in the UK. We quantified recent trends in asthma prevalence and burden in a UK population-based cohort (1‒17-year-olds). Methods: The Clinical Practice...
5.
Morgan A, Maslova E, Kallis C, Sinha I, Roberts G, Tran T, et al.
ERJ Open Res
. 2023 Apr;
9(2).
PMID: 37101737
Background: Prescription of three or more short-acting β-agonist (SABA) canisters per year in adult and adolescent asthma populations is associated with a risk of severe exacerbations; however, evidence in children...
6.
Janson C, Melen E, de Fine Licht S, Telg G, Maslova E, Tran T, et al.
Allergy
. 2023 Mar;
78(8):2311-2314.
PMID: 36919650
No abstract available.
7.
Haughney J, Tran T, Heatley H, Bourdin A, Menzies-Gow A, Jackson D, et al.
NPJ Prim Care Respir Med
. 2023 Mar;
33(1):9.
PMID: 36871120
An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short...
8.
Attar-Zadeh D, Capstick T, Leese D, Arnetorp S, Rapsomaniki E, Peres Da Costa K, et al.
BJGP Open
. 2023 Feb;
7(3).
PMID: 36759020
Background: Poor asthma control is associated with high short-acting β-agonist (SABA) use. Aim: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions...
9.
Heatley H, Tran T, Bourdin A, Menzies-Gow A, Jackson D, Maslova E, et al.
Thorax
. 2022 Dec;
78(9):860-867.
PMID: 36575040
Introduction: Oral corticosteroids (OCS) for asthma are associated with increased risks of developing adverse outcomes (adverse outcomes); no previous study has focused exclusively on intermittent OCS use. Methods: This historical...
10.
Melen E, Nwaru B, Wiklund F, de Fine Licht S, Telg G, Maslova E, et al.
Pediatr Allergy Immunol
. 2022 Nov;
33(11):e13885.
PMID: 36433853
Background: In adults and adolescents with asthma, use of ≥3 short-acting β -agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains...